Loading clinical trials...
Loading clinical trials...
This study will be an open label, dose escalation study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated daily quaque die (QD) doses given over 21 days (Day 3...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT07330258 · Parkinson's Disease
NCT06508801 · Parkinson's Disease and Parkinsonism
NCT07384429 · Parkinson's Disease, Insomnia, and more
NCT02119611 · Parkinson's Disease
NCT07310264 · Healthy Volunteers (HV), Parkinson's Disease (PD)
Orange Coast Memorial Medical Center
Fountain Valley, California
The Parkinson's and Movement Disorder Institute
Fountain Valley, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions